Role of Ayurveda based non-invasive intervention in management of ischemic heart disease patient of diabetes


  • Rohit Sane Department of MD, Madhavbaug Cardiac Hospitals and Clinics, Thane, Maharashtra, India
  • Pramod Manohar Department of intensivist, Madhavbaug Khopoli Cardiac Hospital, Thane, Maharashtra, India
  • Rahul Mandole Department of Research and Development, Madhavbaug Cardiac Clinic and Hospital, Thane, Maharashtra, India
  • Gurudatta Amin Madhavbaug Cardiac Clinic and Hospital, Thane, Maharashtra, India
  • Pravin Ghadigaokar Madhavbaug Cardiac Clinic and Hospital, Thane, Maharashtra, India



Ischemic heart disease, Ischemia reversal program, Ayurveda, Panchkarma, VO2 peak, Dukes treadmill score


Background: The aim of the study was to determine the effectiveness of IRP therapy in patients of myocardial ischemia attending Madhavbaug clinics in Vidarbha region, Maharashtra.

Methods: This was a retrospective study conducted from June 2019 to December 2019, wherein we identified the data of patients suffering from IHD (positive for inducible ischemia from stress test) of either gender or any age, and who had attended the Out-patient departments (OPDs) of Madhavbaug clinics across India. The data of patients who had been administered IRP with minimum 7 sittings over a span of 12 weeks were considered for the study.

Results: In the present study, medical records of 50 patients of IHD were analyzed.  At the end of IRP therapy there was statistically significant reduction in weight, BMI, SBP, and DBP. VO2 peak was improved at the end of therapy i.e. 26.51±5.93 ml/kg/min as compared to baseline i.e.; 15.62±5.36 ml/kg/min and the difference was highly statistically significant (p<0.001). DTS improved from -2.93±5.88 at baseline to 3.21±6.03 at week 12 of IRP therapy and the difference was highly statistically significant (p<0.0001).

Conclusions: Findings of present study suggest that IRP can serve as effective therapeutic option for the management of myocardial ischemia.


WHO. Global Status Report on Non-Communicable Diseases. Switzerland: WHO; 2014.

Fuster V, Kelly B. Board for Global Health. Promoting Cardiovascular Health in Developing World: A Critical Challenge to Achieve Global Health. Washington, DC: Institutes of Medicine; 2010.

Forouzanfar MH, Moran AE, Flaxman AD, Roth G, Mensah GA, Ezzati M, et al. Assessing the global burden of ischemic heart disease, part 2: analytic methods and estimates of the global epidemiology of ischemic heart disease in 2010. Glob Heart. 2012;7(4):331-42.

Sane R, Gond B, Raje G. Evaluation of the efficacy of Ischemia Reversal Program (IRP) in patients suffering from Ischemic Heart Disease (IHD) with known history of Hypertension: A Retrospective Study. J Ayu Med Sci. 2018;3(2):377-83.

5. Institute of Health Metrics and Evaluation. GBD Profile: India, 2021Available at: Accessed on 06 November 2021.

Krishnan MN. Coronary heart disease and risk factors in India - on the brink of an epidemic? Indian Heart J. 2012;64(4):364-7.

Ali MK, Narayan KM, Tandon N. Diabetes & coronary heart disease: current perspectives. Indian J Med Res. 2010;132(5):584-97.

Gupta R, Yusuf S. Challenges in management and prevention of ischemic heart disease in low socioeconomic status people in LLMICs. BMC Med. 2019;17(1):209.

Karthikeyan G, Xavier D, Prabhakaran D, Pais P. Perspectives on the management of coronary artery disease in India. Heart. 2007;93(11):1334-8.

Saeed A, Larik F, Channar P. The Heart and Herbs: Back to the Nature. J Health Med Informat. 2015;6(6):1-11.

Taghadosi M, Arani Z, Gilani H. Quality of life in patients with ischemic heart disease. J Nurs Midwif Sci. 2014;1(1):19-26.

Lippi G, Franchini M, Cervellin G. Diagnosis and management of ischemic heart disease. Semin Thromb Hemost. 2013;39(2):202-13.

Liperoti R, Vetrano DL, Bernabei R, Onder G. Herbal Medications in Cardiovascular Medicine. J Am Coll Cardiol. 2017;69(9):1188-199.

Lairikyengbam SK, Davies AG. Interpreting exercise treadmill tests needs scoring system. BMJ. 2002;325(7361):443.

Buttar K, Saboo N, Kacker S. A review: Maximal oxygen uptake (VO2 max) and its estimation methods. Int J Phys Educ Sports Health. 2019;6(6):24-32.

Jetté M, Sidney K, Blümchen G. Metabolic equivalents (METS) in exercise testing, exercise prescription, and evaluation of functional capacity. Clin Cardiol. 1990;13(8):555-65.

Sherwani SI, Khan HA, Ekhzaimy A, Masood A, Sakharkar MK. Significance of HbA1c Test in Diagnosis and Prognosis of Diabetic Patients. Biomark Insights. 2016;11:95-104.

Wu CY, Hu HY, Chou YJ, Huang N, Chou YC, Li CP. High Blood Pressure and All-Cause and Cardiovascular Disease Mortalities in Community-Dwelling Older Adults. Medicine (Baltimore). 2015;94(47):2160.

Lele SS, Macfarlane D, Morrison S, Thomson H, Khafagi F, Frenneaux M. Determinants of exercise capacity in patients with coronary artery disease and mild to moderate systolic dysfunction. Role of heart rate and diastolic filling abnormalities. Eur Heart J. 1996;17(2):204-12.

César MC, Montesano FT, Diniz RV, Almeida DR, Tebexreni AS, Barros TL. Cardiopulmonary responses to exercise in patients of different age group with congestive heart failure. Arq Bras Cardiol. 2006;86(1):14-8.

Sane R, Sabir I, Naik M. Comprehensive Diabetes Care (CDC) Management Program in Type II Diabetic Obese Patients. Int J Ayu Pharma Res. 2018;6(6):6-12.

Gupta R, Mohan I, Narula J. Trends in Coronary Heart Disease Epidemiology in India. Ann Glob Health. 2016;82(2):307-15.




How to Cite

Sane, R., Manohar, P., Mandole, R., Amin, G., & Ghadigaokar, P. (2021). Role of Ayurveda based non-invasive intervention in management of ischemic heart disease patient of diabetes. International Journal of Research in Medical Sciences, 10(1), 196–201.



Original Research Articles